Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$543K Buy
3,105
+5
+0.2% +$1K 0.02% 667
2026
Q2
$690K Buy
3,100
+311
+11% +$56.5K 0.03% 523
2026
Q1
$429K Buy
2,789
+418
+18% +$56.7K 0.02% 651
2025
Q4
$269K Buy
2,371
+881
+59% +$107K 0.01% 837
2025
Q3
$198K Buy
1,490
+43
+3% +$5.9K 0.01% 984
2025
Q2
$206K Sell
1,447
-88
-6% -$12.5K 0.01% 899
2025
Q1
$235K Sell
1,535
-52
-3% -$8.17K 0.02% 695
2024
Q4
$237K Buy
1,587
+272
+21% +$42.6K 0.02% 620
2024
Q3
$216K Buy
1,315
+240
+22% +$35.5K 0.02% 589
2024
Q2
$149K Buy
1,075
+418
+64% +$57.6K 0.02% 599
2024
Q1
$90.7K Buy
657
+104
+19% +$12.5K 0.02% 693
2023
Q4
$59.8K Buy
+553
New +$51.1K 0.02% 798

Other funds holding DVA

GAMMA Investing's DVA Position: Q3 2026 in Review

GAMMA Investing increased its DaVita (DVA) stake by 0.16% in Q3 2026, buying an estimated $1K and bringing the position to 3,105 shares worth $543K. The position accounts for 0.02% of the portfolio, ranked #667.

GAMMA Investing first reported a position in DVA in Q4 2023 and has held it in 12 quarters since. The position peaked at $690K in Q2 2026. 17 funds tracked by Wall St. Rank hold DVA as of Q3 2026.

  • GAMMA Investing held 3,105 shares of DaVita worth $543K as of Q3 2026.
  • GAMMA Investing bought 5 DaVita shares in Q3 2026, an estimated $1K.
  • DaVita made up 0.02% of GAMMA Investing's portfolio in Q3 2026, its #667 holding.
  • GAMMA Investing first reported a position in DaVita in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's DaVita position peaked at $690K in Q2 2026.
  • 17 funds tracked by Wall St. Rank held DaVita as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.